During her PhD she gained knowledge in the fields of Inorganic and Radiopharmaceutical Chemistry focusing on the development of targeted radioprobes for cancer diagnostic and therapy. Her current work is focused on the development of highly specific materials for novel materials discovery and applications, spanning from challenging separations to targeted drug release relying on molecularly imprinted polymers (MIPs), high affinity adsorbers and functionalized PEDOT nanoparticles. After completing her PhD, she continued expanding her knowledge and skills in different fields: development of small molecules as transmembrane transporters and cytotoxicity studies at FCUL and, since the beginning of 2014, at IST, she develops her research in the field of process separation, where she was the leader of a research project, funded by FCT (PTDC/QEQ-PRS/4157/2014, SelectHost: Innovative and efficient platforms for the removal of genotoxic impurities) under the scope of active pharmaceutical ingredient (API) purification, targeting genotoxic impurity removal with MIPs and polybenzimidazole (PBI) modified polymers. Teresa Esteves also engaged in new challenges, addressing water resources recycling in food industry, and waste valorisation with isolation of molecules of interest to the pharmaceutical industry, with emphasis on new separation processes using nanofiltration membranes, commercial adsorbers and MIP development. She has also engaged in the co-supervision of PhD students, from Chemical Engineering and Bioengineering, and in the supervision of several MSc students (Bioengineering and Nanosystems, Biological Engineering, Pharmaceutical Engineering, Biotechnology, Biomedical Engineering).Overall, her research is focused on the development of novel materials (adsorbers, MIPs, organic solvent nanofiltration membranes) and separation processes to meet challenging separations in the Pharma and Food industries and for targeted drug release using some of these platforms.